Oscar Health, Inc. (NYSE:OSCR - Get Free Report) Director Mario Schlosser sold 150,000 shares of the stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $30.79, for a total transaction of $4,618,500.00. Following the completion of the sale, the director owned 480,866 shares of the company's stock, valued at approximately $14,805,864.14. This trade represents a 23.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Mario Schlosser also recently made the following trade(s):
- On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00.
- On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $4,333,550.00.
- On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00.
- On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total value of $748,592.80.
Oscar Health Trading Down 1.5%
NYSE OSCR opened at $30.00 on Tuesday. The business's fifty day moving average is $30.30 and its 200-day moving average is $22.25. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market capitalization of $9.26 billion, a price-to-earnings ratio of 21.43, a PEG ratio of 0.63 and a beta of 2.36. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $33.55.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.70. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm's quarterly revenue was up 70.4% compared to the same quarter last year. During the same quarter last year, the company posted ($0.89) earnings per share. Equities research analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current year.
Institutional Investors Weigh In On Oscar Health
Several institutional investors have recently made changes to their positions in the stock. California State Teachers Retirement System boosted its holdings in shares of Oscar Health by 3,214.2% in the second quarter. California State Teachers Retirement System now owns 7,803,043 shares of the company's stock worth $222,543,000 after acquiring an additional 7,567,600 shares during the period. Comprehensive Financial Planning Inc. PA bought a new position in Oscar Health in the 2nd quarter worth about $309,000. AXQ Capital LP purchased a new position in Oscar Health during the 2nd quarter valued at about $1,059,000. Nykredit A S purchased a new position in Oscar Health during the 2nd quarter valued at about $130,000. Finally, Wellington Management Group LLP increased its position in shares of Oscar Health by 65.6% during the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock valued at $17,217,000 after buying an additional 239,109 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts recently commented on OSCR shares. Wolfe Research assumed coverage on shares of Oscar Health in a report on Tuesday, May 5th. They issued a "peer perform" rating on the stock. UBS Group increased their price objective on Oscar Health from $20.00 to $26.00 and gave the company a "neutral" rating in a report on Friday, August 7th. The Goldman Sachs Group reissued a "neutral" rating and issued a $30.00 target price on shares of Oscar Health in a research report on Tuesday, August 11th. Wells Fargo & Company upped their price target on Oscar Health from $20.00 to $27.00 and gave the company an "equal weight" rating in a research report on Thursday, August 13th. Finally, Weiss Ratings raised shares of Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, Oscar Health has a consensus rating of "Hold" and a consensus price target of $26.22.
View Our Latest Research Report on Oscar Health
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
